Aldosterone antagonist

WikiDoc Resources for Aldosterone antagonist
Articles
Most recent articles on Aldosterone antagonist Most cited articles on Aldosterone antagonist Review articles on Aldosterone antagonist Articles on Aldosterone antagonist in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Aldosterone antagonist Images of Aldosterone antagonist Photos of Aldosterone antagonist Podcasts & MP3s on Aldosterone antagonist Videos on Aldosterone antagonist
Evidence Based Medicine
Cochrane Collaboration on Aldosterone antagonist Bandolier on Aldosterone antagonist TRIP on Aldosterone antagonist
Clinical Trials
Ongoing Trials on Aldosterone antagonist at Clinical Trials.gov Trial results on Aldosterone antagonist Clinical Trials on Aldosterone antagonist at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Aldosterone antagonist NICE Guidance on Aldosterone antagonist NHS PRODIGY Guidance FDA on Aldosterone antagonist CDC on Aldosterone antagonist
Books
Books on Aldosterone antagonist
News
Aldosterone antagonist in the news Be alerted to news on Aldosterone antagonist News trends on Aldosterone antagonist
Commentary
Blogs on Aldosterone antagonist
Definitions
Definitions of Aldosterone antagonist
Patient Resources / Community
Patient resources on Aldosterone antagonist Discussion groups on Aldosterone antagonist Patient Handouts on Aldosterone antagonist Directions to Hospitals Treating Aldosterone antagonist Risk calculators and risk factors for Aldosterone antagonist
Healthcare Provider Resources
Symptoms of Aldosterone antagonist Causes & Risk Factors for Aldosterone antagonist Diagnostic studies for Aldosterone antagonist Treatment of Aldosterone antagonist
Continuing Medical Education (CME)
CME Programs on Aldosterone antagonist
International
Aldosterone antagonist en Espanol Aldosterone antagonist en Francais
Business
Aldosterone antagonist in the Marketplace Patents on Aldosterone antagonist
Experimental / Informatics
List of terms related to Aldosterone antagonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

also see Congestive heart failure aldosterone antagonists

Overview

Aldosterone antagonist refers to drugs which antagonise the action of aldosterone at mineralocorticoid receptors. This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of chronic heart failure. Spironolactone, the first member of the class, is also used in the management of hyperaldosteronism (including Conn's syndrome) and female hirsutism.

Mode of action

Aldosterone antagonists are, as the name suggests, receptor antagonists at the mineralocorticoid receptor. Antagonism of these receptors inhibits sodium resorption in the distal tubule of the nephron in the kidneys. This interferes with sodium/potassium exchange, reducing urinary potassium excretion and weakly increasing water excretion (diuresis).

Their adjunctive use in congestive heart failure relates to their additive diuretic effect in combination with other drugs, reducing edema and decreasing the cardiac workload.

Examples

Members of this class in clinical use include:

• Spironolactone
• Eplerenone

Related Chapters

• Potassium-sparing diuretic
• ATC_code_C03#C03DA_Aldosterone_antagonists

Resources

• Aldosterone+Antagonists at the US National Library of Medicine Medical Subject Headings (MeSH)
• Template:MeshPharmaList